Hap Trading, LLC Abbott Laboratories Transaction History

Hap Trading, LLC

$1.15 Trillion
Q4 2024

A detailed history of Hap Trading, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Hap Trading, LLC holds 16,800 shares of ABT stock, worth $2.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,800

Previous 13,700 22.63%

Holding current value

$2.19 Million

Previous $48.5 Million 62.79%

% of portfolio

0.0%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $1.18 Million - $1.41 Million	12,330 New	12,330 $1.19 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $356,463 - $412,718	3,684 Added 27.11%	17,274 $1.67 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $163,822 - $198,008	1,605 Added 13.39%	13,590 $1.48 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $675,454 - $823,672	-5,924 Reduced 33.08%	11,985 $1.42 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $535,250 - $655,384	4,633 Added 34.9%	17,909 $2.52 Million
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $793,001 - $933,476	-7,496 Reduced 36.09%	13,276 $1.54 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $881,319 - $1.06 Million	-14,493 Reduced 41.1%	20,772 $1.52 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $699,417 - $771,947	12,149 Added 52.56%	35,265 $2.15 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $1.75 Million - $1.98 Million	-31,174 Reduced 57.42%	23,116 $1.39 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $449,516 - $481,253	8,374 Added 18.24%	54,290 $3.1 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $2.21 Million - $2.46 Million	45,916	45,916 $2.45 Million

Others Institutions Holding ABT

# of Institutions

3,336

Shares Held

1.36B

Call Options Held

10M

Put Options Held

9.48M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account